Woerwag Pharma Operations Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Woerwag Pharma Operations Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing

Secondary Activities: All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | Warehousing and Storage | Other Information Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Marketing Research and Public Opinion Polling

Full name: Woerwag Pharma Operations Sp. z o.o.

Profile Updated: March 31, 2024

Woerwag Pharma Operations Sp. z o.o. is based in Poland, with the head office in Konstantynow Lodzki. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on December 31, 2021. In 2022, the company reported a net sales revenue increase of 66.23%. Its’ total assets recorded a growth of 64.86%.

Headquarters
Ul. Gen. Mariana Langiewicza 58
Konstantynow Lodzki; Lodzkie; Postal Code: 95-050

Contact Details: Purchase the Woerwag Pharma Operations Sp. z o.o. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Woerwag Pharma Operations Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Woerwag Pharma Operations Sp. z o.o. report to view the information.

Incorporation Date:

December 31, 2021

Key Executives

Purchase this report to view the information.

Management Board Member

Purchase this report to view the information.

Management Board Member

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Woerwag Pharma Operations Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

66.23%▲

Total operating revenue

66.17%▲

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total assets

64.86%▲

Total equity

66.2%▲

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt to Equity Ratio

-24.2%▼

Quick Ratio

0.34%▲

Cash Ratio

-0.16%▼

Similar companies